Showing results (951-960 of 1,565) with videos related to
Sort By:
Pageof 157
Expert Review of Hematology|March 10, 2018
Current and emerging treatment options for a patient with a second relapse of Hodgkin's lymphomaAvyakta Kallam, James O ArmitageExpert Review of Hematology|October 29, 2019
Curcumin: hopeful treatment of hemophilic arthropathy via inhibition of inflammation and angiogenesisFatemeh Norooznezhad, E Carlos Rodriguez-Merchan, Soheila Asadi, et al.Expert Review of Hematology|December 12, 2018
Brentuximab vedotin in T-cell lymphomaCarrie Van Der Weyden, Michael Dickinson, James Whisstock, et al.Expert Review of Hematology|August 18, 2017
CPX-351 in acute myeloid leukemia: can a new formulation maximize the efficacy of old compounds?Claudia Brunetti, Luisa Anelli, Antonella Zagaria, et al.Expert Review of Hematology|October 31, 2017
Treatment approach for elderly and unfit patients with chronic lymphocytic leukemiaIdanna Innocenti, Francesco Autore, Raffaella Pasquale, et al.Expert Review of Hematology|February 6, 2018
GATA1 insufficiencies in primary myelofibrosis and other hematopoietic disorders: consequences for therapyTe Ling, John D Crispino, Maria Zingariello, et al.Expert Review of Hematology|January 24, 2018
Use of cord blood derived T-cells in cancer immunotherapy: milestones achieved and future perspectivesVania Lo Presti, Stefan Nierkens, Jaap Jan Boelens, et al.Expert Review of Hematology|January 30, 2018
Hematopoietic stem cell transplant in adults with acute lymphoblastic leukemia: the present stateSalwa S Saadeh, Mark R LitzowExpert Review of Hematology|January 9, 2018
New concepts in the treatment and diagnosis of amyloidosisPaolo Milani, Giovanni Palladini, Giampaolo MerliniExpert Review of Hematology|January 31, 2018
Are BTK and PLCG2 mutations necessary and sufficient for ibrutinib resistance in chronic lymphocytic leukemia?Benjamin L Lampson, Jennifer R BrownPageof 157